Phase
Condition
Dementia
Alzheimer's Disease
Mild Cognitive Impairment
Treatment
N/AClinical Study ID
Ages 60-100 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participants should be able to maintain 10seconds stand feet apart withoutassistance The Validity of FRAILBESTest in mild cognitive impairmentinstitutionalized patients will be made of subgroup categories: Frail/Non-frail;Cognition preserved/Mild cognitive impairment patients and Institutionalizedpatients/community living individuals.
Frailty will be determine by Fried phenotype Those scoring 3 or more out of 5 willbe classify as frail and those scoring 2 or less as non-frail individuals.Mini-Mental State Examination (MMSE) cognition status could be preserved or altered (Score >24-30).
Community living individuals will be non-frail and cognition should preserved theywill be assign to Group A.
Frail institutionalized individual's (scoring from 24 to 26 at MMSE) will be assignto Group B Frail institutionalized individual's (scoring = or > to 27 at MMSE) willbe assign to Group C Non frail Institutionalized individuals with cognitionpreserved (scoring = or > to 27 at MMSE) will be assign to group D.
Exclusion
Exclusion Criteria:
Orthopedic unstable conditions
Moderate or severe cognitive status Score <24 at MMSE
Inability to understand indications or communicate with testers.
Sustaining severe cardiac, vascular or respiratory diseases or conditions thatcontraindicate physical activity
Presenting a condition for which, in the opinion of the researchers, the evaluationmay pose a risk to their health
Not having autonomy to decide about their voluntary participation in the study
Study Design
Study Description
Connect with a study center
Universidad de Zaragoza
Zaragoza, 50009
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.